1.
Yu X, Liu J, Qiu H, Hao H, Zhu J, Peng S. Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer. Bosn J of Basic Med Sci [Internet]. 2021Apr.1 [cited 2021Apr.18];21(2):198-07. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/4746